Welcome to Alberta.

A dynamic ecosystem to conduct clinical trials.

World-class research capabilities, a diverse patient population and an effective ethics framework make Alberta a premier destination to conduct high-quality clinical trials.

If you're considering where to conduct your next clinical trial—it's time you considered Alberta.

Alberta offers a dynamic clinical trial environment where academic institutes, research organizations and investigators collaborate with industry to pursue the development of new treatments and technologies that improve the health of people across the globe.

That’s why hundreds of industry partners – from startups to multinational organizations – rely on Alberta’s capabilities to conduct groundbreaking clinical trials across a range of therapeutic areas.

Why choose Alberta for your clinical trial?

Our province’s unique advantages enable increased trial efficiencies, reduced operating costs, and faster times to market, all while maintaining the highest quality standards.


Centralized and streamlined provincial processes contribute to efficiency at every stage of the research lifecycle.


Highly skilled investigators, cutting-edge facilities and an integrated healthcare environment enable high-quality clinical trials.


An innovative, business-friendly environment and competitive tax incentives for R&D activities.

Success Stories

Featured event

Inventures 2022


Alberta Innovates, Digital Health, Featured Event, Innovation, Inventures

Join moonshots, unicorns and disrupters LIVE in Calgary June 1-3, 2022 for Inventures, the must-attend event of 2022. Don’t miss this opportunity to meet

June 1 - June 3

If you’re seeking an Alberta investigator or site for your clinical trial, we can help.

Clinical Trials Alberta can help you navigate the Alberta research environment and accelerate your trials by:

  • Providing information about conducting clinical trials in Alberta, including regulatory and ethics information.

  • Identifying and connecting you to relevant investigators, research sites, trial networks and service providers.

  • Addressing project-related concerns and challenges.